1. Home
  2. HLIT vs AKBA Comparison

HLIT vs AKBA Comparison

Compare HLIT & AKBA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HLIT
  • AKBA
  • Stock Information
  • Founded
  • HLIT 1988
  • AKBA 2007
  • Country
  • HLIT United States
  • AKBA United States
  • Employees
  • HLIT N/A
  • AKBA N/A
  • Industry
  • HLIT Radio And Television Broadcasting And Communications Equipment
  • AKBA Biotechnology: Pharmaceutical Preparations
  • Sector
  • HLIT Technology
  • AKBA Health Care
  • Exchange
  • HLIT Nasdaq
  • AKBA Nasdaq
  • Market Cap
  • HLIT 1.0B
  • AKBA 958.6M
  • IPO Year
  • HLIT 1995
  • AKBA 2014
  • Fundamental
  • Price
  • HLIT $8.88
  • AKBA $3.68
  • Analyst Decision
  • HLIT Buy
  • AKBA Strong Buy
  • Analyst Count
  • HLIT 6
  • AKBA 5
  • Target Price
  • HLIT $12.33
  • AKBA $6.90
  • AVG Volume (30 Days)
  • HLIT 750.7K
  • AKBA 6.4M
  • Earning Date
  • HLIT 07-28-2025
  • AKBA 08-07-2025
  • Dividend Yield
  • HLIT N/A
  • AKBA N/A
  • EPS Growth
  • HLIT N/A
  • AKBA N/A
  • EPS
  • HLIT 0.44
  • AKBA N/A
  • Revenue
  • HLIT $689,797,000.00
  • AKBA $184,909,000.00
  • Revenue This Year
  • HLIT N/A
  • AKBA $26.88
  • Revenue Next Year
  • HLIT $21.63
  • AKBA $44.34
  • P/E Ratio
  • HLIT $20.07
  • AKBA N/A
  • Revenue Growth
  • HLIT 20.53
  • AKBA N/A
  • 52 Week Low
  • HLIT $7.91
  • AKBA $0.80
  • 52 Week High
  • HLIT $15.46
  • AKBA $4.08
  • Technical
  • Relative Strength Index (RSI)
  • HLIT 43.09
  • AKBA 64.49
  • Support Level
  • HLIT $8.67
  • AKBA $3.46
  • Resistance Level
  • HLIT $9.74
  • AKBA $3.98
  • Average True Range (ATR)
  • HLIT 0.24
  • AKBA 0.25
  • MACD
  • HLIT -0.06
  • AKBA -0.04
  • Stochastic Oscillator
  • HLIT 19.63
  • AKBA 64.20

About HLIT Harmonic Inc.

Harmonic Inc engaged in broadband access solutions that enable broadband operators to more efficiently and effectively deploy high-speed internet for data, voice, and video services for their customers and versatile and high-performance video delivery software, products, system solutions and services that enable its customers to efficiently create, prepare, store, playout and deliver a full range of high-quality broadcast and streaming video services to consumer devices, including televisions, personal computers, laptops, tablets, and smartphones. It has two segments, Broadband which provides broadband access solutions and related services, and Others; and Video business provides video processing and production and playout solutions and services, and Others.

About AKBA Akebia Therapeutics Inc.

Akebia Therapeutics Inc is a fully integrated biopharmaceutical company. The Company's operating segment is the business of developing and commercializing novel therapeutics for people with kidney disease. The current portfolio of the company includes Auryxia (ferric citrate), a medicine approved and marketed in the United States for the control of serum phosphorus levels in adult patients with dialysis-dependent chronic kidney disease and the treatment of iron deficiency anemia, in adult patients with non-dialysis-dependent chronic kidney disease, Vafseo (vadadustat), an oral hypoxia-inducible factor prolyl hydroxylase, inhibitor approved in Japan for the treatment of anemia due to chronic kidney disease, in adult patients, HIF-PH inhibitors in preclinical development.

Share on Social Networks: